ERAS in Liver Surgery
ERASliver
Enhanced Recovery After Surgery: Compliance to the Program in Liver Surgery and Factors Associated With Drop-out
1 other identifier
observational
126
1 country
1
Brief Summary
Enhanced Recovery After Surgery (ERAS) Program (EP) is widely applied to obtain a reduction in post-operative length of hospital stay and a faster restoration of pre-operative patient conditions. However, in Western countries, adherence to EP in liver surgery is still difficult to achieve due to deep-rooted traditional practices. In our Institute, since 2019, EP has been applied pursuing 18/23 items identified by 2016 guidelines. At all consecutive patients who underwent elective liver surgery in our Institution, EP was proposed and their adherence to ERAS items was measured before, during and after surgery. Data were retrospectively collected and analysed, particularly focusing on EP items. Primary outcome was compliance to EP, defined as at least 80% of accomplished items per patient. Secondary outcome was adherence to each ERAS item, while tertiary outcome was detecting the variables associated with program drop out.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedFirst Submitted
Initial submission to the registry
October 24, 2022
CompletedFirst Posted
Study publicly available on registry
October 28, 2022
CompletedOctober 28, 2022
October 1, 2022
2.6 years
October 24, 2022
October 24, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Compliance to ERAS program
Compliance to ERAS program was defined as at least 80% of accomplished items per patient
32 months
Secondary Outcomes (2)
Compliance to ERAS items
32 months
Drop-out factors
32 months
Study Arms (2)
ERAS-in
Patients who completed ERAS program
ERAS-out
Patients who dropped-out from ERAS program
Interventions
Eligibility Criteria
126 patients were consecutively enrolled from January 2019 to July 2021
You may qualify if:
- patients candidates to surgery for benign or malignant liver disease
- liver resection with curative intent
You may not qualify if:
- refusal to participate at the EP
- incapability to acquire informed consent
- cognitive impairment that can prejudice the patient comprehension of the EP
- liver surgery with palliative or diagnostic intent or non-resective liver surgery
- emergency surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ospedale San Gerardo
Monza, MB, 20900, Italy
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 24, 2022
First Posted
October 28, 2022
Study Start
January 1, 2019
Primary Completion
July 31, 2021
Study Completion
September 30, 2021
Last Updated
October 28, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share